The longitudinal assessment of a wide range of surrogate measures of insulin secretion and/or sensitivity allowed us to demonstrate for the first time that abnormalities of both β-cell function and peripheral insulin action contribute to the impairment of glucose homeostasis and the development of DM in WS patients, as in classical type 2 DM [22]. The gene discussed is INS; the disease is diabetes mellitus.